The second half of the year could bring similarly important results from clinical trials testing drugs for Alzheimer’s disease, cancer and vision loss. Positive data, if it comes, might give biotech a needed boost. #biotech #clini…lnkd.in/gCdSu5dG lnkd.in/gRkn62K9